{"title":"Healthcare burden and clinical outcomes of polypharmacy in older adults: a population-based cohort study in South Korea.","authors":"Zhaoyan Piao, Kyung Sun Oh, Euna Han","doi":"10.1186/s13690-025-01703-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Polypharmacy is a prevalent issue in aging societies, with potential health and cost implications. This study evaluated the impact of polypharmacy on hospitalization rates and healthcare expenditure among individuals aged 65 years and older in South Korea.</p><p><strong>Methods: </strong>We analyzed integrated data from the 2012-2016 Korean National Health and Nutrition Examination Survey alongside administrative claims data from the National Health Insurance Service and Health Insurance Review and Assessment Service. Medical costs were calculated as total annual per capita expenses, encompassing outpatient visit, hospitalization, and drug costs. Key clinical outcomes included hospitalization and mortality. To evaluate the effects of polypharmacy on outpatient visits, medication costs, and total expenditures, we performed a multivariable linear regression analysis. A two-part model was used to estimate hospitalization costs.</p><p><strong>Results: </strong>The analysis included 3,297 participants. Polypharmacy was significantly associated with higher hospitalization risk (OR, 1.52; 95% CI, 1.28-1.81) and mortality (OR, 3.17; 95% CI, 1.19-8.44). Polypharmacy also corresponded with increased healthcare expenditures, particularly in total, outpatient visit, and medication costs, with the highest associations observed in individuals aged 65-79 and those living alone. Multivariable linear regression revealed a higher annual average total healthcare cost by 872,018 KRW, with outpatient and medication costs by 324,879 KRW and 536,721 KRW, respectively (p < 0.05) for polypharmacy group than the counterparts.</p><p><strong>Conclusion: </strong>This study demonstrates that polypharmacy among older adults is significantly associated with higher healthcare costs and risks of hospitalization and mortality. Findings suggest that integrated care models, incorporating medication reviews and tailored care plans, alongside community resources to support isolated seniors, may mitigate healthcare costs and improve health outcomes.</p>","PeriodicalId":48578,"journal":{"name":"Archives of Public Health","volume":"83 1","pages":"217"},"PeriodicalIF":3.2000,"publicationDate":"2025-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12376462/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Public Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13690-025-01703-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Polypharmacy is a prevalent issue in aging societies, with potential health and cost implications. This study evaluated the impact of polypharmacy on hospitalization rates and healthcare expenditure among individuals aged 65 years and older in South Korea.
Methods: We analyzed integrated data from the 2012-2016 Korean National Health and Nutrition Examination Survey alongside administrative claims data from the National Health Insurance Service and Health Insurance Review and Assessment Service. Medical costs were calculated as total annual per capita expenses, encompassing outpatient visit, hospitalization, and drug costs. Key clinical outcomes included hospitalization and mortality. To evaluate the effects of polypharmacy on outpatient visits, medication costs, and total expenditures, we performed a multivariable linear regression analysis. A two-part model was used to estimate hospitalization costs.
Results: The analysis included 3,297 participants. Polypharmacy was significantly associated with higher hospitalization risk (OR, 1.52; 95% CI, 1.28-1.81) and mortality (OR, 3.17; 95% CI, 1.19-8.44). Polypharmacy also corresponded with increased healthcare expenditures, particularly in total, outpatient visit, and medication costs, with the highest associations observed in individuals aged 65-79 and those living alone. Multivariable linear regression revealed a higher annual average total healthcare cost by 872,018 KRW, with outpatient and medication costs by 324,879 KRW and 536,721 KRW, respectively (p < 0.05) for polypharmacy group than the counterparts.
Conclusion: This study demonstrates that polypharmacy among older adults is significantly associated with higher healthcare costs and risks of hospitalization and mortality. Findings suggest that integrated care models, incorporating medication reviews and tailored care plans, alongside community resources to support isolated seniors, may mitigate healthcare costs and improve health outcomes.
期刊介绍:
rchives of Public Health is a broad scope public health journal, dedicated to publishing all sound science in the field of public health. The journal aims to better the understanding of the health of populations. The journal contributes to public health knowledge, enhances the interaction between research, policy and practice and stimulates public health monitoring and indicator development. The journal considers submissions on health outcomes and their determinants, with clear statements about the public health and policy implications. Archives of Public Health welcomes methodological papers (e.g., on study design and bias), papers on health services research, health economics, community interventions, and epidemiological studies dealing with international comparisons, the determinants of inequality in health, and the environmental, behavioural, social, demographic and occupational correlates of health and diseases.